An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach
- PMID: 16099596
- DOI: 10.1016/j.ijrobp.2005.05.005
An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach
Abstract
Purpose: The role of adjuvant chemoradiotherapy (CRT) in D2-resected gastric-cancer patients has not been defined yet. We investigated the effect of postoperative chemoradiotherapy on the relapse rate and survival rate of patients with D2-resected gastric cancer.
Methods and materials: From August 1995 to April 2001, 544 patients received postoperative CRT after curative D2 resection. During the same period of time, 446 patients received surgery without further adjuvant treatment. The adjuvant CRT consisted of 400 mg/m2 of fluorouracil plus 20 mg/m2 of leucovorin for 5 days, followed by 4,500 cGy of radiotherapy for 5 weeks, with fluorouracil and leucovorin on the first 4 and the last 3 days of radiotherapy. Two 5-day cycles of fluorouracil and leucovorin were given 4 weeks after the completion of radiotherapy.
Results: The median duration of overall survival was significantly longer in the CRT group than in the comparison group (95.3 months vs. 62.6 months), which corresponds to a hazard ratio for death of 0.80 (p = 0.0200) or a reduction of 20% in the risk of death in the CRT group. The 5-year survival rates were consistently longer in the CRT group at Stages II, IIIA, IIIB, and IV than those in the comparison group. The CRT was associated with increases in the median duration of relapse-free survival (75.6 months vs. 52.7 months; hazard ratio for relapse, 0.80, p = 0.0160).
Conclusion: Our results highly suggest that the postoperative chemoradiotherapy in D2-resected gastric-cancer patients can prolong survival and decrease recurrence.
Similar articles
-
Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma.Cancer J. 2008 Jul-Aug;14(4):269-75. doi: 10.1097/PPO.0b013e318178d23a. Cancer J. 2008. PMID: 18677137
-
Intraoperative radiotherapy combined with adjuvant chemoradiotherapy for locally advanced gastric adenocarcinoma.Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1488-94. doi: 10.1016/j.ijrobp.2008.03.012. Epub 2008 Jun 4. Int J Radiat Oncol Biol Phys. 2008. PMID: 18538489
-
Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response.J Clin Oncol. 2006 Aug 20;24(24):3953-8. doi: 10.1200/JCO.2006.06.4840. J Clin Oncol. 2006. PMID: 16921048 Clinical Trial.
-
Role of post-operative chemoradiation in resected gastric cancer.J Surg Oncol. 2005 Jun 1;90(3):166-70. doi: 10.1002/jso.20223. J Surg Oncol. 2005. PMID: 15895449 Review.
-
[Role of adjuvant chemoradiotherapy in the treatment of gastric carcinoma].Cas Lek Cesk. 2003;142 Suppl 1:26-8. Cas Lek Cesk. 2003. PMID: 12924046 Review. Czech.
Cited by
-
Chemotherapy for operable gastric cancer: current perspectives.Indian J Surg Oncol. 2011 Dec;2(4):334-42. doi: 10.1007/s13193-012-0139-1. Epub 2012 Mar 1. Indian J Surg Oncol. 2011. PMID: 23204792 Free PMC article.
-
[Adjuvant chemoradiotherapy in gastric adenocarcinoma: about 34 cases and review of the literature].Pan Afr Med J. 2014 Sep 24;19:70. doi: 10.11604/pamj.2014.19.70.5312. eCollection 2014. Pan Afr Med J. 2014. PMID: 25709728 Free PMC article. Review. French.
-
Postoperative chemoradiotherapy in gastric cancer -- a Phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy.Br J Cancer. 2007 Sep 17;97(6):712-6. doi: 10.1038/sj.bjc.6603965. Br J Cancer. 2007. PMID: 17848909 Free PMC article. Clinical Trial.
-
Relationship between epithelial cell adhesion molecule (EpCAM) overexpression and gastric cancer patients: A systematic review and meta-analysis.PLoS One. 2017 Apr 12;12(4):e0175357. doi: 10.1371/journal.pone.0175357. eCollection 2017. PLoS One. 2017. PMID: 28403178 Free PMC article. Review.
-
Adjuvant chemoradiotherapy after d2-lymphadenectomy for gastric cancer: the role of n-ratio in patient selection. results of a single cancer center.Radiat Oncol. 2012 Oct 15;7:169. doi: 10.1186/1748-717X-7-169. Radiat Oncol. 2012. PMID: 23068190 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous